Pan Pan

Pan Pan

Auto-generated profile, based on publicly available information

Pan Pan

College of Pulmonary and Critical Care Medicine Chinese PLA General Hospital Beijing China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
PPPan Pan
Pan Pan
YLYichao Li
Yichao Li
YXYongjiu Xiao
Yongjiu Xiao
BHBingchao Han
Bingchao Han
Longxiang SuLongxiang Su
Longxiang Su
Lixin XieLixin Xie
Lixin Xie
Background: Patients with COVID-19 in the intensive care unit (ICU) have a high mortality rate, and methods to assess patients’ prognosis early and administer precise treatment are of great significance. Objective: The aim of this study was to use machine learning to construct a model for the analysis of risk factors and prediction of mortality among ICU patients with COVID-19. Methods: In this study, 123 patients with COVID-19 in the ICU of Vulcan Hill Hospital were retrospectively selected from the database, and the data were randomly divided into a training data set (n=98) and test data set (n=25) with a 4:1 ratio. Significance tests, correlation analysis, and factor analysis were used to screen 100 potential risk factors individually. Conventional logistic regression methods and four machine learning algorithms were used to construct the risk prediction model for the prognosis of patients with COVID-19 in the ICU. The performance of these machine learning models was measured by the area under the receiver operating characteristic curve (AUC). Interpretation and evaluation of the risk prediction model were performed using calibration curves, SHapley Additive exPlanations (SHAP), Local Interpretable Model-Agnostic Explanations (LIME), etc, to ensure its stability and reliability. The outcome was based on the ICU deaths recorded from the database. Results: Layer-by-layer screening of 100 potential risk factors finally revealed 8 important risk factors that were included in the risk prediction model: lymphocyte percentage, prothrombin time, lactate dehydrogenase, total bilirubin, eosinophil percentage, creatinine, neutrophil percentage, and albumin level. Finally, an eXtreme Gradient Boosting (XGBoost) model established with the 8 important risk factors showed the best recognition ability in the training set of 5-fold cross validation (AUC=0.86) and the verification queue (AUC=0.92). The calibration curve showed that the risk predicted by the model was in good agreement with the actual risk. In addition, using the SHAP and LIME algorithms, feature interpretation and sample prediction interpretation algorithms of the XGBoost black box model were implemented. Additionally, the model was translated into a web-based risk calculator that is freely available for public usage. Conclusions: The 8-factor XGBoost model predicts risk of death in ICU patients with COVID-19 well; it initially demonstrates stability and can be used effectively to predict COVID-19 prognosis in ICU patients.

16 October 2023 in The FASEB Journal
Verified
Journal Article
Closed access
PPPan Pan
Pan Pan
JCJie Chen
Jie Chen
FXFei Xie
Fei Xie
YGYinghua Guo
Yinghua Guo
XLXudong Liu
Xudong Liu
Longxiang SuLongxiang Su
Longxiang Su

29 April 2026 in View
Verified
Journal Article
Open access
WZWanyi Zhang
Wanyi Zhang
TWTing Wang
Ting Wang
MYMengying Yao
Mengying Yao
LSLongxiang Su
Longxiang Su
LXLixin Xie
Lixin Xie
PPPan Pan
Pan Pan
Neurological sequelae, ranging from acute brain dysfunction (e.g., delirium) to long‐term cognitive impairment, are increasingly recognized as significant complications in survivors of critical care units, particularly in patients with lung injury caused by severe pulmonary inflammation mechanical ventilation. However, the underlying mechanisms linking lung injury to neurological dysfunction remain poorly understood. Traditional in vitro and animal models face significant limitations in replicating complex, bidirectional interactions between lungs and the brain. This review narratively summarizes the current understanding of how severe pulmonary infections contribute to brain dysfunction, focusing on key pathophysiological pathways such as systemic inflammation, infection‐associated hypoxia, mechanical ventilation‐induced injury, and alterations in the pulmonary microenvironment. We highlight recent advances in the development and application of lung and brain organoids, as well as multiorgan‐on‐a‐chip technologies, which enable modeling of complex inter‐organ crosstalk that traditional models cannot capture. Furthermore, we discuss how these cutting‐edge platforms can simulate clinically relevant processes—such as ventilator‐associated pneumonia, acute respiratory distress syndrome, and infection‐induced cognitive impairment‐offering promising avenues for preclinical mechanistic studies and informing future therapeutic development and patient stratification in critical illness. By critically analyzing the current limitations of organoid and organ‐on‐a‐chip systems, we propose future directions to enhance their mechanistic fidelity, standardization, and translational potential. This comprehensive approach ultimately improve our understanding of lung‒brain interactions targeting multiorgan dysfunction in intensive care setting.

2 August 2020 in JMIR Preprints
Verified
Preprint
Open access
PPPan Pan
Pan Pan
YLYichao Li
Yichao Li
YXYongjiu Xiao
Yongjiu Xiao
BHBingchao Han
Bingchao Han
Longxiang SuLongxiang Su
Longxiang Su
Lixin XieLixin Xie
Lixin Xie
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Patients with COVID-19 in the intensive care unit (ICU) have a high mortality rate, and methods to assess patients’ prognosis early and administer precise treatment are of great significance. Objective: The aim of this study was to use machine learning to construct a model for the analysis of risk factors and prediction of mortality among ICU patients with COVID-19. Methods: In this study, 123 patients with COVID-19 in the ICU of Vulcan Hill Hospital were retrospectively selected from the database, and the data were randomly divided into a training data set (n=98) and test data set (n=25) with a 4:1 ratio. Significance tests, correlation analysis, and factor analysis were used to screen 100 potential risk factors individually. Conventional logistic regression methods and four machine learning algorithms were used to construct the risk prediction model for the prognosis of patients with COVID-19 in the ICU. The performance of these machine learning models was measured by the area under the receiver operating characteristic curve (AUC). Interpretation and evaluation of the risk prediction model were performed using calibration curves, SHapley Additive exPlanations (SHAP), Local Interpretable Model-Agnostic Explanations (LIME), etc, to ensure its stability and reliability. The outcome was based on the ICU deaths recorded from the database. Results: Layer-by-layer screening of 100 potential risk factors finally revealed 8 important risk factors that were included in the risk prediction model: lymphocyte percentage, prothrombin time, lactate dehydrogenase, total bilirubin, eosinophil percentage, creatinine, neutrophil percentage, and albumin level. Finally, an eXtreme Gradient Boosting (XGBoost) model established with the 8 important risk factors showed the best recognition ability in the training set of 5-fold cross validation (AUC=0.86) and the verification queue (AUC=0.92). The calibration curve showed that the risk predicted by the model was in good agreement with the actual risk. In addition, using the SHAP and LIME algorithms, feature interpretation and sample prediction interpretation algorithms of the XGBoost black box model were implemented. Additionally, the model was translated into a web-based risk calculator that is freely available for public usage. Conclusions: The 8-factor XGBoost model predicts risk of death in ICU patients with COVID-19 well; it initially demonstrates stability and can be used effectively to predict COVID-19 prognosis in ICU patients.